| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.9B | $4.1B | $4.0B | $3.8B | $0.9B | $0.8B | $0.8B |
| Cost of Revenue | $2.6B | $2.8B | $2.8B | $2.7B | $2.5B | $2.1B | $2.3B | $2.3B |
| Gross Profit | — | — | — | — | — | $0.3B | $0.3B | $0.3B |
| R&D Expense | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B |
| Operating Income | $0.2B | $0.1B | $0.2B | $0.7B | $0.6B | $0.3B | $0.6B | $0.7B |
| Net Income | $0.0B | $0.1B | $-0.0B | $0.3B | $0.4B | $0.1B | $0.1B | $0.3B |
| EPS (Basic) | $0.21 | $0.85 | $-0.03 | $2.00 | $2.30 | $0.77 | $0.34 | $1.55 |
| EPS (Diluted) | $0.21 | $0.85 | $-0.03 | $1.99 | $2.28 | $0.77 | $0.34 | $1.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.8B | $7.1B | $7.7B | $8.8B | $8.6B | $7.8B | $6.8B | $6.8B |
| Current Assets | $2.0B | $2.0B | $2.1B | $2.8B | $3.1B | $3.0B | $2.0B | $1.9B |
| Cash & Equivalents | $0.6B | $0.6B | $0.5B | $1.2B | $1.7B | $1.9B | $0.8B | $0.7B |
| Total Liabilities | $4.0B | $4.3B | $4.7B | $5.6B | $5.5B | $5.1B | $4.3B | $4.2B |
| Current Liabilities | $0.8B | $0.7B | $0.8B | $1.2B | $0.8B | $1.5B | $0.6B | $0.6B |
| Stockholders' Equity | $2.8B | $2.9B | $3.0B | $3.1B | $3.1B | $2.7B | $2.6B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.1B | $-0.0B | $-0.2B | $-0.6B | $-0.9B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.4B | $-1.0B | $-0.4B | $0.2B | $0.7B | $-0.4B | $-0.4B |